Sagimet Biosciences Inc. (SGMT) Misses Q2 EPS by 3529c
Tweet
Share
E-mailGet Alerts SGMT Hot Sheet
Join SI Premium – FREE
Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($35.80), $35.29 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Assumes Sagimet Biosciences Inc (SGMT) at Sell
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
